# Tempest Therapeutics, Inc.: Form DEF 14A, filed Jun 8, 2026

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: DEF 14A
- Filed: 2026-06-08
- Accepted by EDGAR: Jun 8, 2026, 16:06 ET
- Period: 2026-06-18
- Accession: 0001140361-26-024453
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000114036126024453/ny20072803x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000114036126024453/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000114036126024453/ny20072803x2_def14a.htm

Filed Jun 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-024453. Last ingested by Listed: Nov 3, 2026, 14:25 ET. No prices; not investment advice.